scispace - formally typeset
Journal ArticleDOI

Where's the high-grade cervical neoplasia? The importance of minimally abnormal Papanicolaou diagnoses

TLDR
Recognition of the importance of equivocal and mild Papanicolaou test abnormalities in the subsequent diagnosis of high-grade cervical neoplasia emphasizes the need for accurate and cost-effective triage of the large population of women with minimally abnormal PapanIColaou diagnoses.
About
This article is published in Obstetrics & Gynecology.The article was published on 1998-06-01. It has received 271 citations till now. The article focuses on the topics: Papanicolaou Test & Bethesda system.

read more

Citations
More filters
Journal ArticleDOI

Human papillomavirus and cervical cancer

TL;DR: The new HPV-oriented model of cervical carcinogenesis should gradually replace older morphological models based only on cytology and histology, and can minimise the incidence of cervical cancer, and the morbidity and mortality it causes, even in low-resource settings.
Journal ArticleDOI

2001 Consensus Guidelines for the Management of Women with Cervical Cytological Abnormalities.

TL;DR: Management of women with atypical squamous cells (ASC) depends on whether the Papanicolaou test is subcategorized as of undetermined significance (ASC-US) or as cannot exclude high-grade squamous intraepithelial lesion (HSIL) (asc-H).
Journal ArticleDOI

Human Papillomavirus Testing in the Prevention of Cervical Cancer

TL;DR: The natural history and cervical carcinogenicity of HPV is summarized, the promise and uncertainties of currently available screening methods are discussed, and the greatest potential for reduction in cervical cancer rates from HPV screening is in low-resource regions that can implement infrequent rounds of low-cost HPV testing and treatment.
Journal ArticleDOI

Identifying Women With Cervical Neoplasia: Using Human Papillomavirus DNA Testing for Equivocal Papanicolaou Results

TL;DR: Whether human papillomavirus DNA testing of residual material from liquid-based Pap tests and referral of cases found to be HPV-positive directly to colposcopy could provide sensitive detection of underlying HSILs in women with ASCUS Pap results, compared with repeat Pap testing is investigated.
Journal ArticleDOI

Evidence for Frequent Regression of Cervical Intraepithelial Neoplasia-Grade 2

TL;DR: There was evidence that approximately 40% of undiagnosed Cin 2 will regress over 2 years, but CIN 2 caused by HPV-16 may be less likely to regress than CIN2 caused by other high-risk–HPV genotypes.
References
More filters
Journal ArticleDOI

Human papillomavirus testing by hybrid capture appears to be useful in triaging women with a cytologic diagnosis of atypical squamous cells of undetermined significance.

TL;DR: Testing for human papillomavirus deoxyribonucleic acid with hybrid capture appears to offer an effective means by which patients whose cervical Papanicolaou smears have been read as atypical squamous cells of undetermined significance could be triaged for colposcopy.
Journal ArticleDOI

Human papillomavirus testing by hybrid capture appears to be useful in triaging women with a cytologic of diagnosis of atypical squamous cells of unde termined significance

TL;DR: Testing for human papillomavirus deoxyribonucleic acid with hybrid capture appears to offer an effective means by which patients whose cervical Papanicolaou smears have been read as atypical squamous cells of undetermined significance could be triaged for colposcopy.
Journal ArticleDOI

Comparison of management algorithms for the evaluation of women with low-grade cytologic abnormalities

TL;DR: A repeat Papanicolaou smear combined with a HPV DNA test is a sensitive alternative to colposcopic evaluation for the detection of CIN in women referred for a previous low-grade abnormal PAP smear, but because of the low specificity, it results in only modest cost reductions compared to the more standard triage of performing colposcopy at the first visit.
Journal ArticleDOI

Atypical squamous cells of undetermined significance: interlaboratory comparison and quality assurance monitors.

TL;DR: Interlaboratory comparison and quality assurance methods for evaluating the rate and outcome of ASCUS serve to validate laboratory criteria and consequent clinical follow‐up and the ratio ASCUS/SIL may serve as a useful laboratory monitor.
Related Papers (5)